Shanghai Zhudong develops invasive brain-computer interface systems for patients with motor and language impairments.
Founded in 2026 and based in Shanghai, China, Shanghai Zhudong Technology develops invasive brain-computer interface products, including the Tian Shu motion BCI for patients with disabilities caused by stroke, spinal cord injury, and ALS. In August 2026, the company raised CNY 330 million in angel funding led by Casstar Capital, with participation from Legend Star, Unity Ventures, Dalton Venture, Innoangel Fund, Miracle Light Venture Capital, Jifeng Ventures, and Jiadao Private Capital. The funding will support facilities, equipment, clinical trials, and team growth.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in